It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

CAMBRIDGE, MA – Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a biopharmaceutical company focused on cellular metabolism to treat cancer and rare genetic diseases, announced the upcoming departure of a ...

🇩📧️2️⃣️📦️💾️ The official source repository for the DMAIL implementation of the EMAIL 2 Email Samples specification, creating a sample of emails.

There is no evidence that a senior Food and Drug Administration (FDA) worker was arrested after samples of the H5N1 bird flu virus were found in his fridge. The narrative stems from a website ...

Federal workers often include a wide range of gender and pronoun information as part of their email signature with increasing frequency under the Biden administration. Pronoun usage in the federal ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

Indian pharmaceutical companies are grappling with significant challenges, including declining R&D productivity, patent expirations, and increased scrutiny from global regulators. To address these ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s US trading debut, after pricing its $126.4 million initial public ...

Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, People’s ...

Ascentage aims to raise $149 mln via US IPO Plans to offer 7.3 mln American depositary shares at $20.34 each Company's shares already listed in Hong Kong Jan 21 (Reuters) - Ascentage Pharma (6855 ...